GLP-1 and diabetes medicines in Spain and who pays

Key rules

• Diabetes: Public funding applies to type 2 diabetes, generally after metformin or other treatment has not controlled it.
• Weight loss: Wegovy and Mounjaro for obesity alone are generally paid in full by you.
• Regional approval: Some regions require an inspection approval before the pharmacy dispenses a funded prescription.
• Supply: Shortages have happened, so check the medicine's current status before relying on a prescription.

Who pays: the short answer

Public health pays for these medicines only in restricted cases, mainly type 2 diabetes. If you want the medicine for weight loss alone, expect to pay the full price yourself. Supply has also been uneven, so a prescription does not always mean the pharmacy has the pen.

Type 2 diabetes: public funding

Semaglutide (such as Ozempic) and other GLP-1 drugs are funded for type 2 diabetes, with conditions. Funding generally requires that metformin or other treatment has not controlled your diabetes well enough. In some cases it applies only if you have certain risk factors.

Some regions also ask for an inspection approval (visa) before the pharmacy can dispense a funded prescription. Your diabetes doctor may therefore ask for extra approval before prescribing. Ask your doctor or health centre how it works in your region.

Weight loss: usually private pay

Weight-loss products such as Wegovy and Mounjaro for obesity are not generally funded when obesity is the only reason. You buy them privately, with a Spanish prescription, and pay in full. Limited funding for people with obesity, a high BMI and other health conditions has been considered but is not general. Ask your doctor whether anything applies to you now.

What it costs

Pharmacy prices are regulated and set in an official price list called the Nomenclátor. The price depends on the product, the dose pen and the pack size. Higher doses cost more, so your monthly cost changes as your dose changes. Ask a pharmacy for the current price of your exact product before you buy.

Supply problems

Spain has had shortages of semaglutide since 2022 and 2023, driven by worldwide demand for weight-loss use. The medicines agency asked doctors to prescribe it only for its approved uses. Supply has varied since. Look up your medicine in CIMA, the agency's medicines database, and in its supply-problems list (Problemas de suministro). They show the current status and alternatives. If your medicine is short, ask your doctor about an alternative.

The checklist and questions below walk you through what to ask your doctor and pharmacy.

Checklist

• Ask your doctor why you need the medicine: type 2 diabetes or weight loss.

• Ask whether public funding applies to you, for example if metformin or other treatment has not controlled your type 2 diabetes.

• Plan to pay in full if the medicine is for weight loss alone, such as Wegovy or Mounjaro for obesity.

Frequently asked questions

Will public health pay for Wegovy or Mounjaro if I only want to lose weight?

No, Wegovy and Mounjaro for obesity alone are generally not funded by the public health system, so you pay for them privately. Limited funding for people with a high BMI and other health conditions has been considered, but it is not general. Ask your doctor whether your case could qualify.

Why might my diabetes doctor ask for extra approval before prescribing Ozempic?

Funding for type 2 diabetes usually requires that metformin or other treatment has not controlled your diabetes well enough. In some regions a medical inspection approval (visa) is also needed, and sometimes only patients with certain risk factors qualify. Ask your doctor which conditions apply where you live.

How do I find out what a semaglutide pen costs in a pharmacy?

Semaglutide has a regulated price in Spain, set in the Nomenclátor, the Ministry of Health's official medicines price list. The price depends on the product, the dose pen and the pack size, and higher doses cost more. Ask a pharmacy for the current price with your Spanish prescription.

Where can I check whether Ozempic is currently in short supply?

You can check the current status of each medicine in CIMA, the Spanish medicines agency's database, and in its supply-problems list (Problemas de suministro). The list also shows alternatives. Supply was tight from 2022 and 2023 because of high demand for weight loss, and it has varied since.